MAZE - Maze Therapeutics, Inc.
44.83
-0.470 -1.048%
Share volume: 383,490
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$45.30
-0.47
-0.01%
Summary score
33%
Profitability
35%
Dept financing
21%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-9.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
11.17%
Debt ratio change over timeo
0%
Current Ratio
16.9%
Quick Ratio
0%
Cash Position Ratio
15.07%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-9.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
11.17%
Debt ratio change over timeo
0%
Current Ratio
16.9%
Quick Ratio
0%
Cash Position Ratio
15.07%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.81%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
10.1%
Debt ratio change over time
0%
Current Ratio
17.7%
Quick Ratio
0%
Cash Position Ratio
14.33%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MAZE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 28.34% | 5.51% | 6.15% |
| Return on assets | -9.22% | 3.06% | 3.18% | 2.21% |
| Return on sales | 0% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | 0% | 6.42% | 3.22% | 6.7% |
| Profitability | 0% | 98% | 66% | 68% |
| Total debt ratio | 11.17% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | 0% | 12.76% | 169.64% | 13.01% |
| Dept financing | 3% | 27% | 43% | 14% |
| Current Ratio | 16.9% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 15.07% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 24% | 20% | 29% |
| Short-term ratios | MAZE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -9.22% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 33% | 50% | 26% |
| Total debt ratio | 11.17% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 11% |
| Current Ratio | 16.9% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 15.07% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 19% | 26% | 29% |